布地奈德主要治疗什么病症？

It is mainly used for chronic reversible airway obstructive diseases such as bronchial asthma. The atomized dosage of budesonide is generally 1-2 mg once for adults and twice a day; for children, 0.5-1 mg once and twice a day. The maintenance dose should be individualized, that is, the lowest dose to maintain no symptoms. It is recommended that adults take 0.5-1 mg twice a day and children 0.25-0.5 mg twice a day.

Patients should take budesonide about half an hour before meals and swallow the budesonide whole with plenty of liquid (such as a glass of water). Treatment to maintain remission in autoimmune hepatitis (adults over 18 years of age) should be continued for at least 24 months. Its termination is possible only if biochemical remission is sustained and signs of inflammation are absent in liver biopsy. Termination of budesonide therapy: It should not be stopped suddenly but gradually withdrawn (tapered). During the first week, the daily dose should be reduced to two capsules, one in the evening and one at night. During the second week, take only one capsule in the morning. Treatment can then be stopped. For specific information, please consult your attending physician.

Budesonide is a locally acting, non-systemic corticosteroid. The dosage form is a new oral tablet made using the patented technology of MMX multi-matrix system. The recommended dosage of budesonide for the treatment of mild to moderately active Crohn's disease: Adults: 9 mg daily for up to 8 weeks; repeat the 8-week treatment process for recurrent active disease. Pediatrics 8 to 17 years weighing more than 25 kg: 9 mg once daily for up to 8 weeks, then 6 mg once daily for 2 weeks.

Dosage to maintain clinical remission in mild to moderate Crohn's disease: Adults: 6 mg daily for up to 3 months; discontinue after 3 months of completion of tapering. Continuation of treatment beyond 3 months has not been shown to provide substantial clinical benefit. When switching from oral prednisolone, begin tapering the prednisolone dose and simultaneously initiate budesonide.